Oseni, E.A.; Blumenthal, M.; Izard, S.; Qiu, M.; Mone, A.; Swaminath, A.; Sultan, K.
Analysis of the Impact of Preadmission, Inpatient, and Discharge Opioid Exposure and Dose on 30- and 90-Day Hospital Readmissions in Patients with Inflammatory Bowel Disease Exacerbations. J. Clin. Med. 2025, 14, 7658.
https://doi.org/10.3390/jcm14217658
AMA Style
Oseni EA, Blumenthal M, Izard S, Qiu M, Mone A, Swaminath A, Sultan K.
Analysis of the Impact of Preadmission, Inpatient, and Discharge Opioid Exposure and Dose on 30- and 90-Day Hospital Readmissions in Patients with Inflammatory Bowel Disease Exacerbations. Journal of Clinical Medicine. 2025; 14(21):7658.
https://doi.org/10.3390/jcm14217658
Chicago/Turabian Style
Oseni, Ellen A., Miriam Blumenthal, Stephanie Izard, Michael Qiu, Anjali Mone, Arun Swaminath, and Keith Sultan.
2025. "Analysis of the Impact of Preadmission, Inpatient, and Discharge Opioid Exposure and Dose on 30- and 90-Day Hospital Readmissions in Patients with Inflammatory Bowel Disease Exacerbations" Journal of Clinical Medicine 14, no. 21: 7658.
https://doi.org/10.3390/jcm14217658
APA Style
Oseni, E. A., Blumenthal, M., Izard, S., Qiu, M., Mone, A., Swaminath, A., & Sultan, K.
(2025). Analysis of the Impact of Preadmission, Inpatient, and Discharge Opioid Exposure and Dose on 30- and 90-Day Hospital Readmissions in Patients with Inflammatory Bowel Disease Exacerbations. Journal of Clinical Medicine, 14(21), 7658.
https://doi.org/10.3390/jcm14217658
